Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO

Product News   Jun 03, 2014

 
Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News

The exclusive licence enables the development and commercialisation of 5hmC technologies for epigenetic biomarker discovery.

READ MORE

New ADME/Tox Products Enable More In Vivo-like Testing

Product News

Corning® TransportoCells™ ABC Transporter Vesicles and Corning Supersomes™ Ultra Human Aldehyde Oxidase (AO) Enzyme are now commercially available.

READ MORE

A Simple, Sensitive Method to Detect Cancer-linked Transcription Factors

Product News

New fluorescent peptide imaging application of PXi System allows german researchers to easily detect leukaemia associated proteins.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE